Literature DB >> 8270266

Recombinant cytokines as immunological adjuvants.

A D Nash1, S A Lofthouse, G J Barcham, H J Jacobs, K Ashman, E N Meeusen, M R Brandon, A E Andrews.   

Abstract

This paper describes the bacterial expression and purification of bioactive recombinant ovine interleukin-2 (rovIL-2), interleukin-1 alpha (rovIL-1 alpha) and tumour necrosis factor alpha. These purified proteins had specific activities in appropriate bioassays of 1 x 10(7) 1 x 10(7) and 1 x 10(5) U/mg, respectively. Recombinant ovIL-1 alpha was assessed as an immunological adjuvant for the sheep response to the model protein avidin. When delivered either intradermally or intramuscularly in conjunction with avidin in aluminium hydroxide the rovIL-1 alpha significantly enhanced the secondary humoral response. Doses of 1, 10 or 100 micrograms per sheep enhanced the humoral response to a similar extent. Recombinant ovIL-1 beta had similar adjuvant activity in that it was demonstrated to significantly enhance the sheep humoral response to an experimental H. contortus antigen. This increase in specific antibody, however, did not correlate with enhanced protection against infection with third stage H. contortus larvae. In addition incorporation of rovIL-1 beta into the formulation was shown not to alter the isotype profile of H. contortus antigen specific antibody.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270266     DOI: 10.1038/icb.1993.43

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  3 in total

Review 1.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria.

Authors:  Kuan-Hsun Lin; Ai-Ping Hsu; Jui-Hung Shien; Tien-Jye Chang; Jiunn-Wang Liao; Jeng-Rung Chen; Chuen-Fu Lin; Wei-Li Hsu
Journal:  Vaccine       Date:  2012-04-21       Impact factor: 3.641

3.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.